https://www.selleckchem.com/pr....oducts/derazantinib.
26; 95% confidence interval [CI] 5.72 to 9.21; p less then 0.01), systemic lupus erythematosus (HR 3.15; 95% CI 2.41 to 4.11; p less then 0.01), rheumatoid arthritis (HR 1.39; 95% CI 1.13 to 1.71; p less then 0.01), and human immunodeficiency virus (HR 1.28; 95% CI 0.99 to 1.66; p = 0.06). There was no association between psoriasis or inflammatory bowel disease and incident HF, although patients with those CIDs with higher levels of C-reactive protein had higher risks for HF than controls. CONCLUSIONS Systemic sclerosis and systemi
Like
Comment
Share
